Figure 2From: MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4Transfection of miR-182 inhibitor and its negative control oligonucleotides (NC) into A549 cells. qRT-PCR showed significant under-expression of miR-182 in the transfected cells compared with control cells.Back to article page